Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06486909 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Shunt-dependency After aSAH - Role of Early Hyperglycaemia in CSF and Blood

Study acronym: HCP-Glc
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Mar 2026 to Mar 2027
    • Study completion date: Sep 2027 to Sep 2028
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this study is to confirm the association of early increased glucose levels in cerebro-spinal fluid (CSF) and ventriculo-peritoneal-shunt (VPS)-dependency also evaluating the influence of blood glucose on VPS dependency in patients suffering from an aneurysmal subarachnoid haemorrhage (aSAH). The main questions we aim to answer are: * Is there an association of glucose levels on VPS dependency in patients requiring extra-ventricular-drain (EVD) placement for aSAH? * In addition, if there is, what is the influence the course of glucose levels has on VPS dependency? Glucose levels in CSF and serum will be measured on admission, or in case of CSF, upon EVD placement. Glucose in CSF will then be measured every day until EVD removal together with serum glucose. Follow-up will be conducted in person after 3 and 6 months.
Trial Details
NCT Number NCT06486909
Lead Sponsor Isabel Hostettler
Collaborators: Kantonsspital Aarau, University Hospital, Basel, Switzerland
Conditions
(from sponsor)		 Aneurysm, Ruptured, Hyperglycemia, Hydrocephalus
Related terms Aneurysm, Ruptured, Hydrocephalus, Hyperglycemia
Enrollment 160 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov